News-Medical.Net on MSN

Study identifies PTX-3 as potential marker for long COVID and tissue damage

A research team working at MedUni Vienna has demonstrated that a specific component of the immune system (PTX-3) remains at ...

Sudan Ebola virus can persist in survivors for months, study shows

More than half of survivors of the Sudan Ebola virus still suffer serious health problems two years post-infection and the ...

The mosquito-borne virus that changes the brain and raises diabetes risk

Scientists have long studied how Zika virus harms the developing brain, but until now, its effects on the adult brain were less clear ...
Grist on MSN

In Arizona, a fight against a deadly fungus is under threat from Trump’s health policies

What might become the world’s first-ever fungal vaccine, discovered by a team of researchers at the Valley Fever Center for ...

ZUSDURI™ Clinical Review Published in Reviews in Urology™ Highlights Durable Efficacy and Manageable Safety Profile in Recurrent Low-Grade, Intermediate-Risk Non–Muscle ...

Detailed price information for Urogen Pharma Ltd (URGN-Q) from The Globe and Mail including charting and trades.
Becker's Hospital Review

Recurrent C. diff cases costs hospitals millions: Study

Recurring Clostridioides difficile infections could be costing hospitals millions, an AtlantiCare Regional Medical Center study found. The study, published Sept. 29 in Cambridge Core, included 29 ...
Cochrane

What are the benefits and harms of different SARS-CoV-2 testing methods when trying to stop people from getting sick, going to the hospital, or dying?

Few studies examine how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) tests assist or hinder efforts to prevent illness, hospitalisations, or people dying. Due to weak evidence, we’re ...